Evidence map›Paper›PMID 37455711›Full record

ArticleFrontiers in microbiology2023

Target specific inhibition of West Nile virus envelope glycoprotein and methyltransferase using phytocompounds: an

Shopnil Akash, Imren Bayıl, Md Anisur Rahman, Nobendu Mukerjee, Swastika Maitra, Md Rezaul Islam, Sanchaita Rajkhowa, Arabinda Ghosh, Sami A Al-Hussain, Magdi E A Zaki and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 7 countries.

Shopnil AkashDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
Imren BayılDepartment of Bioinformatics and Computational Biology, Gaziantep University, Gaziantep, Türkiye.
Md Anisur RahmanDepartment of Pharmacy, Islamic University, Kushtia, Bangladesh.
Nobendu MukerjeeDepartment of Microbiology, West Bengal State University, Kolkata, West Bengal, India.
Swastika MaitraDepartment of Microbiology, Adamas University, Kolkata, West Bengal, India.
Md Rezaul IslamDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
Sanchaita RajkhowaCentre for Biotechnology and Bioinformatics, Dibrugarh University, Dibrugarh, Assam, India.
Arabinda GhoshMicrobiology Division, Department of Botany, Gauhati University, Gwahati, Assam, India.
Sami A Al-HussainDepartment of Chemistry, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Magdi E A ZakiDepartment of Chemistry, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Vikash JaiswalDepartment of Cardiovascular Research, Larkin Community Hospital, South Miami, FL, United States.
Sanjit SahGlobal Consortium for Public Health and Research, Datta Meghe Institute of Higher Education and Research, Jawaharlal Nehru Medical College, Wardha, India.
Joshuan J BarbozaEscuela de Medicina, Universidad Cesar Vallejo, Trujillo, Peru.
Ranjit SahTribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.
Daffodil International University · BDImam Mohammad ibn Saud Islamic University · SAAdamas University · INDibrugarh University · INDr. D.Y. Patil Vidyapeeth, Pune · INGauhati University · INGaziantep University · TRIslamic University · BDJawaharlal Nehru Medical College · INLarkin Community Hospital · USUniversidad César Vallejo · PEWest Bengal State University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mosquitoes are the primary vector for West Nile virus, a flavivirus. The virus's ability to infiltrate and establish itself in increasing numbers of nations has made it a persistent threat to public health worldwide. Despite the widespread occurrence of this potentially fatal disease, no effective treatment options are currently on the market. As a result, there is an immediate need for the research and development of novel pharmaceuticals. To begin, molecular docking was performed on two possible West Nile virus target proteins using a panel of twelve natural chemicals, including Apigenin, Resveratrol, Hesperetin, Fungisterol, Lucidone, Ganoderic acid, Curcumin, Kaempferol, Cholic acid, Chlorogenic acid, Pinocembrin, and Sanguinarine. West Nile virus methyltransferase (PDB ID: 2OY0) binding affinities varied from -7.4 to -8.3 kcal/mol, whereas West Nile virus envelope glycoprotein affinities ranged from -6.2 to -8.1 kcal/mol (PDB ID: 2I69). Second, substances with larger molecular weights are less likely to be unhappy with the Lipinski rule. Hence, additional research was carried out without regard to molecular weight. In addition, compounds 01, 02, 03, 05, 06, 07, 08, 09, 10 and 11 are more soluble in water than compound 04 is. Besides, based on maximum binding affinity, best three compounds (Apigenin, Curcumin, and Ganoderic Acid) has been carried out molecular dynamic simulation (MDs) at 100 ns to determine their stability. The MDs data is also reported that these mentioned molecules are highly stable. Finally, advanced principal component analysis (PCA), dynamics cross-correlation matrices (DCCM) analysis, binding free energy and dynamic cross correlation matrix (DCCM) theoretical study is also included to established mentioned phytochemical as a potential drug candidate. Research has indicated that the aforementioned natural substances may be an effective tool in the battle against the dangerous West Nile virus. This study aims to locate a bioactive natural component that might be used as a pharmaceutical.

Indexed as

ADMETdrug-likenessmolecular dockingmolecular dynamic simulationPCAWest Nile virus

Identifiers

PMID37455711
PMCPMC10338848
OpenAlexW4382393618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.